From April 1, 2022 to June 30, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 42,941 shares, representing 0.29% for KRW 1,521.88 million under the buyback announced on December 10, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,170 KRW | +0.06% | -1.55% | +0.41% |
1st Jan change | Capi. | |
---|---|---|
+0.41% | 186M | |
+21.47% | 44.15B | |
+23.27% | 23.02B | |
+19.25% | 15.33B | |
+12.71% | 13.74B | |
+50.07% | 12.16B | |
-10.04% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- A271980 Stock
- News Jeil Pharmaceutical Co.,Ltd
- Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.